Page 27 - GlaxoSmithKline Pharmaceuticals AR 2012

23
• Equity History
Particulars No. of shares issued
(of Rs. 10 each)
Year of issue
Original Holding 18,00,000 1924
Bonus Issue 2,00,000 1947
Bonus Issue 10,00,000 1962
Bonus Issue 24,00,000 1968
Public Issue 18,00,000 1969
Bonus Issue 36,00,000 1977
Bonus Issue 36,00,000 1980
Public cum Rights Issue 56,00,000 1983
Shares allotted to Group Companies 44,89,800 1993
Rights Issue 53,97,700 1993
Bonus Issue 2,98,87,500 1995
Shares issued pursuant to the amalgamation of
SmithKline Beecham Pharmaceuticals (India) Limited
(SBPIL) with the Company in the ratio of one share of
the Company for every two shares of SBPIL issued on
30th November 2001
1,47,00,000 2001
Shares issued pursuant to the amalgamation of Burroughs
Wellcome (India) Limited (BWIL) with the Company in the
ratio of fourteen shares of the Company for every ten
shares of BWIL issued on 29th October 2004
1,28,47,546 2004
Buy back of equity shares ( 26,19,529) 2005
Total 8,47,03,017
• List of top ten shareholders of the Company other than Glaxo Group Limited, Eskaylab
Limited, Burroughs Wellcome International Limited and Castleton Investment Limited who
hold 35.99%, 6.94%, 3.97% and 3.77% shares respectively.
Sr. No. Name of Shareholder % to Equity
1. Life Insurance Corporation of India 5.69
2. Aberdeen Global Indian Equity Fund Mauritius Limited 3.90
3. Aberdeen Global-Emerging Markets Equity Fund 3.61
4. The Aberdeen Emerging Markets Institutional Fund 2.70
5. Aberdeen Global-Asia Pacific Equity Fund 1.58
6. General Insurance Corporation of India 1.18
7. Aberdeen Emerging Markets Equity Fund, A Series of The Aberdeen
Institutional Commingled Funds, LLC.
0.97
8. Investeringsforeningen Danske Invest 0.92
9. Aberdeen Investment Funds Icvc-Aberdeen Asia Pacific Fund 0.80
10. The Oriental Insurance Company Limited 0.79